Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals

Oncogene

Volumn 26, Issue 13, 2007, Pages 1941-1948

  Evans, M K ^a   Yu, C R ^b   Lohani, A ^a   Mahdi, R M ^b   Liu, X ^b   Trzeciak, A R ^a   Egwuagu, C E ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

BRCA1; Breast cancer; Breast cancer cells; DNA hypermethylation; Interferon; SOCS; STAT

Indexed keywords

GAMMA INTERFERON; SOMATOMEDIN C; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; SUPPRESSOR OF CYTOKINE SIGNALING 6; SUPPRESSOR OF CYTOKINE SIGNALING 7; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; METHYLATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROSTATE CANCER; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 33947524972     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209993     Document Type: Article

References (33)

1. Andrews HN, Mullan PB, McWilliams S, Sebelova S, Quinn JE, Gilmore PM et al. (2002). BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem 277: 26225-26232.
2. Aprelikova O, Pace AJ, Fang B, Koller BH, Liu ET. (2001). BRCA1 is a selective co-activator of 14-3-3 sigma gene-transcription in mouse embryonic-stem cells. J Biol Chem 276: 25647-25650.
3. Bowman T, Garcia R, Turkson J, Jove R. (2000). STATs in oncogenesis. Oncogene 19: 2474-2488.
4. Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C et al. (2005). Constitutive SOCS-3 expression protects T-cell lymphoma against growth-inhibition by IFNalpha. Leukemia 19: 209-213.
5. Campbell IL. (2005). Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res Brain Res Rev 48: 166-177.
6. Catteau A, Morris JR. (2002). BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12: 359-371.
7. Clevenger CV. (2004). Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 165: 1449-1460.
8. Coccia EM, Del-Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali G et al. (1999). Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene 18: 2129-2137.
9. Cui JQ, Shao N, Chai Y, Wang H, Reddy ES, Rao VN. (1998). BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator. Oncol Rep 5: 591-595.
10. Darnell Jr JE. (1997). STATs and gene regulation. Science 277: 1630-1635.
11. Darnell JE. (2005). Validating Stat3 in cancer therapy. Nat Med 11: 595-596.
12. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M et al. (2006). Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12: 11-19.
13. Haura EB, Turkson J, Jove R. (2005). Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2: 315-324.
14. He B, You L, Uematsu K, Zang K, Xu Z, Lee AY et al. (2003). SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA 100: 14133-14138.
15. Hilton DJ. (1999). Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55: 1568-1577.
16. Issa JP. (2004). CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
17. Le Provost F, Miyoshi K, Vilotte JL, Bierie B, Robinson GW, Hennighausen L. (2005). SOCS3 promotes apoptosis of mammary differentiated cells. Biochem Biophys Res Commun 338: 1696-1701.
18. Medina D. (2005). Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 12: 483-495.
19. Missiaglia E, Donadelli M, Palmieri M, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR. (2005). Growth delay of human pancreatic-cancer-cells by methylase inhibitor 5-aza-2′-deoxycytidine-treatment is associated with activation of the interferon signalling pathway. Oncogene 24: 199-211.
20. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T et al. (2005). Methylation-silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK-signalings in human hepatocellular carcinoma. Oncogene 24: 6406-6417.
21. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. (2000). Collaboration of signal transducer and activator of transcription-1 (STAT1) and BRCA1 in differential-regulation of IFN-gamma target genes. Proc Natl Acad Sci USA 97: 5208-5213.
22. Raccurt M, Tam SP, Lau P, Mertani HC, Lambert A, Garcia-Caballero T et al. (2003). Suppressor of cytokine-signalling gene expression is elevated in breast-carcinoma. Br J Cancer 89: 524-532.
23. Rottapel R, Ilangumaran S, Neale C, La-Rose J, Ho JM, Nguyen MH et al. (2002). The tumor suppressor activity of SOCS-1. Oncogene 21: 4351-4362.
24. Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T, Kishimoto T. (2000). IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma. J Immunol 164: 5833-5843.
25. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. (2005). Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast-cancer cells. Oncogene 24: 746-760.
26. Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W et al. (2004). Differential hypermethylation of SOCS genes in ovarian and breast-carcinomas. Oncogene 23: 7726-7733.
27. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW et al. (1996). Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818.
28. Teodoridis JM, Hall J, Marsh S, Kannall HD, Smyth C, Curto J et al. (2005). CpG-island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res 65: 8961-8967.
29. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. (1999). CpG-island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686.
30. Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A et al. (2005). SOCS-3 is frequently methylated in head and neck squamous-cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24: 6699-6708.
31. Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L et al. (2005). BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy-number and chromosome-17 aneusomy. Cancer Res 65: 10692-10699.
32. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM et al. (2002). BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99: 7560-7565.
33. Yu CR, Mahdi RM, Ebong S, Vistica BP, Chen J, Guo Y et al. (2004). Cell proliferation and STAT6 pathways are negatively-regulated in T-cells by STAT1 and suppressors of cytokine-signaling. J Immunol 173: 737-746.